Commission to publish details of EU product "safety feature" later this year
This article was originally published in Scrip
Executive Summary
Later this year pharmaceutical firms should find out exact details of the safety features they will have to affix to their prescription drugs in order to comply with EU legislation aimed at preventing falsified medicines entering the legitimate supply chain.
You may also be interested in...
Industry & Regulators To Align Advice on COVID-19 Vaccine Updates
A multi-stakeholder workshop looked at the data needed to support updates to vaccine composition and the time required by manufacturers to update their vaccines, change their manufacturing processes and prepare approval applications.
Denmark Planning To Impose Drug Stockpiling Obligations From July
A new bill is intended to address the increase in medicine supply problems in Denmark in recent years.
National Drug Stockpiles Create ‘False Sense Of Security’
The generics and biosimilars industry body Medicines for Europe says disparate national stockpiling requirements are not a solution to shortages and can bring “significant risks” for the supply chain and access to medicines.